0001841383falseQ3--12-31KYOn January 19, 2021 an aggregate of 7,187,500 founder shares were issued to the Sponsor for an aggregate purchase price of $25,000. Up to 937,500 Founder Shares were subject to forfeiture by the Sponsor, depending on the extent to which the Underwriters’ over-allotment option was exercised. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units and forfeited the remainder of the option. As a result, none of the Class B ordinary shares are subject to forfeiture any longer.On January 31, 2022 the Sponsor executed a settlement agreement in the amount of $255,726 relating to Levere’s IPO legal work. The Sponsor agreed to release Levere from all liability obligations associated with the settlement agreement. As a result, the full amount was recorded to additional paid in capital and was subsequently offset by accretion of trust earnings to Class A Ordinary shares subject to possible redemption which depleted the balance in additional paid in capital.On January 19, 2021 an aggregate of 7,187,500 founder shares were issued to Goggo Network Gmbh (the “Sponsor”) for an aggregate purchase price of $25,000. Up to 937,500 Founder Shares were subject to forfeiture by the Sponsor, depending on the extent to which the Underwriters’ over-allotment option was exercised. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units and forfeited the remainder of the option. As a result, none of the Class B ordinary shares are subject to forfeiture any longer.On January 31, 2022 the Sponsor executed a settlement agreement in the amount of $255,726 relating to Levere’s IPO legal work. The Sponsor agreed to release Levere from all liability obligations associated with the settlement agreement. As a result, the full amount was recorded to additional paid in capital. 0001841383 2022-01-01 2022-09-30 0001841383 2021-01-15 2021-09-30 0001841383 2022-09-30 0001841383 2021-12-31 0001841383 2021-01-15 2021-03-31 0001841383 2021-07-01 2021-09-30 0001841383 2021-04-01 2021-06-30 0001841383 2022-07-01 2022-09-30 0001841383 2022-01-01 2022-03-31 0001841383 2022-04-01 2022-06-30 0001841383 2022-05-13 0001841383 2021-01-14 0001841383 2021-09-30 0001841383 2021-06-30 0001841383 2021-03-31 0001841383 2022-03-31 0001841383 2022-06-30 0001841383 us-gaap:CommonClassBMember 2022-09-30 0001841383 us-gaap:CommonClassAMember 2022-09-30 0001841383 us-gaap:CommonClassAMember lvra:PublicSharesMember 2022-09-30 0001841383 us-gaap:OverAllotmentOptionMember 2022-09-30 0001841383 us-gaap:IPOMember us-gaap:CommonClassAMember 2022-09-30 0001841383 lvra:SponsorMember lvra:WorkingCapitalLoanMember 2022-09-30 0001841383 lvra:WorkingCapitalLoanMember lvra:SponsorMember us-gaap:IPOMember 2022-09-30 0001841383 us-gaap:CommonClassAMember lvra:RedemptionOfWarrantsMember lvra:SharePriceEqualOrMoreTenPointZeroRupeesPerDollarMember 2022-09-30 0001841383 us-gaap:CommonClassAMember lvra:PrivatePlacementWarrantsMember lvra:SharePriceEqualOrMoreTenPointZeroRupeesPerDollarMember 2022-09-30 0001841383 us-gaap:CommonClassAMember lvra:RedemptionOfWarrantsMember lvra:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2022-09-30 0001841383 lvra:PublicWarrantsMember 2022-09-30 0001841383 us-gaap:CommonClassAMember lvra:PublicWarrantsMember 2022-09-30 0001841383 us-gaap:CommonClassAMember lvra:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember 2022-09-30 0001841383 lvra:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2022-09-30 0001841383 lvra:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember 2022-09-30 0001841383 lvra:SponsorMember lvra:SharePriceMoreThanOrEqualsToUsdTwelveMember us-gaap:CommonClassAMember 2022-09-30 0001841383 lvra:SponsorMember 2022-09-30 0001841383 lvra:WorkingCapitalLoanMember 2022-09-30 0001841383 us-gaap:CommonStockSubjectToMandatoryRedemptionMember us-gaap:CommonClassAMember 2022-09-30 0001841383 lvra:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2022-09-30 0001841383 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001841383 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001841383 us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001841383 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member lvra:PrivatePlacementWarrantsMember 2022-09-30 0001841383 lvra:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001841383 lvra:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001841383 lvra:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001841383 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-09-30 0001841383 us-gaap:MeasurementInputSharePriceMember 2022-09-30 0001841383 us-gaap:MeasurementInputPriceVolatilityMember 2022-09-30 0001841383 us-gaap:MeasurementInputExpectedTermMember 2022-09-30 0001841383 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member lvra:UsMoneyMarketMember 2022-09-30 0001841383 us-gaap:FairValueMeasurementsRecurringMember lvra:UsMoneyMarketMember 2022-09-30 0001841383 us-gaap:MeasurementInputExpectedTermMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001841383 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001841383 lvra:MeasurementInputUnderlyingWarrantValueMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001841383 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2022-09-30 0001841383 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001841383 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2022-09-30 0001841383 lvra:PrivatePlacementWarrantsMember 2022-09-30 0001841383 us-gaap:CommonClassBMember 2021-12-31 0001841383 us-gaap:CommonClassAMember 2021-12-31 0001841383 lvra:SponsorMember 2021-12-31 0001841383 us-gaap:CommonClassAMember us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2021-12-31 0001841383 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001841383 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001841383 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841383 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member lvra:PrivatePlacementWarrantsMember 2021-12-31 0001841383 lvra:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841383 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember lvra:PublicWarrantsMember 2021-12-31 0001841383 us-gaap:FairValueMeasurementsRecurringMember lvra:PublicWarrantsMember 2021-12-31 0001841383 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001841383 us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001841383 us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001841383 us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001841383 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member lvra:UsMoneyMarketMember 2021-12-31 0001841383 us-gaap:FairValueMeasurementsRecurringMember lvra:UsMoneyMarketMember 2021-12-31 0001841383 lvra:PrivatePlacementWarrantsMember 2021-12-31 0001841383 lvra:PublicWarrantsMember 2021-12-31 0001841383 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001841383 us-gaap:FairValueInputsLevel3Member 2022-07-01 2022-09-30 0001841383 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001841383 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001841383 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001841383 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001841383 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassAMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassBMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassAMember srt:ScenarioPreviouslyReportedMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassAMember srt:RestatementAdjustmentMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassAMember lvra:AsRestatedMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassBMember srt:ScenarioPreviouslyReportedMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassBMember srt:RestatementAdjustmentMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassBMember lvra:AsRestatedMember 2021-07-01 2021-09-30 0001841383 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001841383 lvra:PrivatePlacementWarrantsMember 2022-01-01 2022-09-30 0001841383 lvra:SponsorMember lvra:PrivatePlacementWarrantsMember 2022-01-01 2022-09-30 0001841383 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-09-30 0001841383 lvra:SponsorMember 2022-01-01 2022-09-30 0001841383 lvra:SponsorMember lvra:WorkingCapitalLoanMember 2022-01-01 2022-09-30 0001841383 lvra:PublicWarrantsMember 2022-01-01 2022-09-30 0001841383 lvra:RedemptionOfWarrantsMember lvra:SharePriceEqualOrMoreTenPointZeroRupeesPerDollarMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001841383 us-gaap:CommonClassAMember lvra:RedemptionOfWarrantsMember lvra:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2022-01-01 2022-09-30 0001841383 us-gaap:CommonClassAMember lvra:PrivatePlacementWarrantsMember lvra:SharePriceEqualOrMoreTenPointZeroRupeesPerDollarMember 2022-01-01 2022-09-30 0001841383 lvra:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001841383 lvra:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2022-01-01 2022-09-30 0001841383 lvra:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember 2022-01-01 2022-09-30 0001841383 lvra:SponsorMember lvra:SharePriceMoreThanOrEqualsToUsdTwelveMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001841383 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001841383 us-gaap:CapitalUnitsMember 2022-01-01 2022-09-30 0001841383 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001841383 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001841383 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001841383 lvra:ConvertiblePromissoryNoteMember 2022-01-01 2022-09-30 0001841383 us-gaap:CommonClassAMember 2021-01-15 2021-09-30 0001841383 us-gaap:CommonClassBMember 2021-01-15 2021-09-30 0001841383 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001841383 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001841383 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-03-31 0001841383 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001841383 us-gaap:FairValueInputsLevel3Member 2022-04-01 2022-06-30 0001841383 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-01-15 2021-03-31 0001841383 us-gaap:AdditionalPaidInCapitalMember 2021-01-15 2021-03-31 0001841383 us-gaap:RetainedEarningsMember 2021-01-15 2021-03-31 0001841383 us-gaap:OverAllotmentOptionMember 2021-01-15 2021-03-31 0001841383 us-gaap:IPOMember 2021-01-15 2021-03-31 0001841383 us-gaap:OverAllotmentOptionMember lvra:FounderSharesMember 2021-01-15 2021-03-31 0001841383 us-gaap:CommonClassBMember lvra:SponsorMember lvra:FounderSharesMember 2021-01-15 2021-03-31 0001841383 lvra:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2021-01-15 2021-03-31 0001841383 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001841383 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001841383 lvra:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-04-01 2021-06-30 0001841383 lvra:SponsorMember us-gaap:CommonClassBMember 2021-03-23 2021-03-23 0001841383 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-03-23 2021-03-23 0001841383 lvra:SponsorMember lvra:OfficeSpaceAdministrativeAndSupportServicesMember 2021-03-23 2021-03-23 0001841383 lvra:PromissoryNoteMember lvra:SponsorMember 2021-03-23 2021-03-23 0001841383 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-03-23 2021-03-23 0001841383 us-gaap:OverAllotmentOptionMember 2021-03-23 2021-03-23 0001841383 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-03-23 0001841383 us-gaap:CommonClassAMember lvra:PublicWarrantsMember 2021-03-23 0001841383 lvra:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2021-03-23 0001841383 lvra:ClericalErrorMember us-gaap:OverAllotmentOptionMember us-gaap:CommonClassBMember lvra:SponsorMember 2021-03-31 2021-03-31 0001841383 us-gaap:OverAllotmentOptionMember 2021-03-31 2021-03-31 0001841383 lvra:SponsorMember us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember lvra:ClericalErrorMember 2021-03-31 2021-03-31 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-31 2021-03-31 0001841383 lvra:SponsorMember us-gaap:CommonClassBMember 2021-09-16 2021-09-16 0001841383 lvra:SponsorMember us-gaap:CommonClassBMember lvra:AfterCorrectionOfClericalErrorMember 2021-09-16 2021-09-16 0001841383 us-gaap:CommonClassBMember us-gaap:CommonStockMember lvra:ExcessSharesForfeitedNowRectifiedMember 2021-09-16 2021-09-16 0001841383 lvra:PrivatePlacementWarrantsMember 2021-03-31 0001841383 lvra:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2021-03-31 0001841383 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001841383 us-gaap:CommonClassBMember lvra:SponsorMember lvra:FounderSharesMember 2021-01-19 2021-01-19 0001841383 lvra:SponsorMember us-gaap:CommonClassBMember lvra:FounderSharesMember 2021-01-19 2021-01-19 0001841383 us-gaap:CommonClassBMember lvra:SponsorMember lvra:FounderSharesMember srt:MaximumMember 2021-01-19 0001841383 srt:MinimumMember lvra:FounderSharesMember lvra:SponsorMember us-gaap:CommonClassBMember 2021-01-19 0001841383 lvra:PromissoryNoteMember lvra:SponsorMember 2021-01-19 0001841383 lvra:SponsorMember us-gaap:CommonClassAMember 2021-03-15 2021-03-15 0001841383 lvra:FounderSharesMember lvra:SponsorMember us-gaap:CommonClassBMember 2021-03-15 2021-03-15 0001841383 us-gaap:FairValueInputsLevel3Member 2021-01-15 2021-12-31 0001841383 us-gaap:CommonClassAMember 2021-01-15 2021-12-31 0001841383 lvra:SponsorMember 2021-01-15 2021-12-31 0001841383 lvra:ConvertiblePromissoryNoteMember lvra:SponsorMember 2022-05-13 2022-05-13 0001841383 lvra:PromissoryNoteMember lvra:SponsorMember 2022-05-13 0001841383 lvra:ConvertiblePromissoryNoteMember lvra:SponsorMember 2022-05-13 0001841383 us-gaap:MeasurementInputExpectedTermMember us-gaap:FairValueInputsLevel3Member 2022-05-13 0001841383 lvra:MeasurementInputUnderlyingWarrantValueMember us-gaap:FairValueInputsLevel3Member 2022-05-13 0001841383 us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member 2022-05-13 0001841383 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2022-05-13 0001841383 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2022-05-13 0001841383 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:FairValueInputsLevel3Member 2022-05-13 0001841383 us-gaap:CommonClassAMember srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-09-30 0001841383 us-gaap:CommonClassAMember srt:RestatementAdjustmentMember 2021-01-01 2021-09-30 0001841383 us-gaap:CommonClassAMember lvra:AsRestatedMember 2021-01-01 2021-09-30 0001841383 us-gaap:CommonClassBMember srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-09-30 0001841383 us-gaap:CommonClassBMember srt:RestatementAdjustmentMember 2021-01-01 2021-09-30 0001841383 us-gaap:CommonClassBMember lvra:AsRestatedMember 2021-01-01 2021-09-30 0001841383 us-gaap:CommonClassAMember 2021-01-25 2021-09-30 0001841383 us-gaap:CommonClassBMember 2021-01-25 2021-09-30 0001841383 lvra:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-01-01 2021-03-31 0001841383 lvra:SponsorMember lvra:SettlementAgreementMember 2022-01-13 2022-01-13 0001841383 lvra:SettlementAgreementMember lvra:SponsorMember 2022-01-31 2022-01-31 0001841383 lvra:OnOrAfterJanuaryOneTwoThousandAndTwentyThreeMember lvra:TheInflationReductionActOfTwoThousandAndTwentyTwoMember 2022-08-16 2022-08-16 0001841383 us-gaap:CommonClassBMember 2022-11-07 0001841383 us-gaap:CommonClassAMember 2022-11-07 0001841383 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001841383 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-09-30 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-09-30 0001841383 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001841383 us-gaap:RetainedEarningsMember 2022-09-30 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-09-30 0001841383 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001841383 us-gaap:RetainedEarningsMember 2021-09-30 0001841383 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-09-30 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001841383 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001841383 us-gaap:RetainedEarningsMember 2021-12-31 0001841383 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001841383 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001841383 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-03-31 0001841383 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001841383 us-gaap:RetainedEarningsMember 2022-03-31 0001841383 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-06-30 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-06-30 0001841383 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001841383 us-gaap:RetainedEarningsMember 2022-06-30 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-01-14 0001841383 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-14 0001841383 us-gaap:AdditionalPaidInCapitalMember 2021-01-14 0001841383 us-gaap:RetainedEarningsMember 2021-01-14 0001841383 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001841383 us-gaap:RetainedEarningsMember 2021-03-31 0001841383 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001841383 us-gaap:RetainedEarningsMember 2021-06-30 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-06-30 0001841383 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-06-30 0001841383 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001841383 us-gaap:FairValueInputsLevel3Member 2021-01-14 iso4217:USD xbrli:shares utr:Month utr:Day xbrli:pure utr:Year iso4217:USD xbrli:shares lvra:PerShare utr:Y utr:D

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934

For the transition period from

Commission File Number001-40243

Levere Holdings Corp.

(Exact name of registrant as specified in its charter)


Cayman Islands		98-1581160
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

PO Box 1093, Boundary Hall, Cricket Square, Grand Cayman Cayman Islands		KY1-1102
(Address of principal executive offices)		(Zip Code)

(345)949-8066

(Registrant’s telephone number, including area code)

Not

Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant	LVRAU	Nasdaq Capital Market
Class A ordinary shares, par value $0.0001 per share	LVRA	Nasdaq Capital Market
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	LVRAW	Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2of

the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in

Rule12b-2of

the Exchange Act). Yes ☒ No ☐

As of

November 7, 20

22, 27,128,532 Class A ordinary shares, par value $0.0001, and 6,782,133 Class B ordinary shares, par value $0.0001, were issued and outstanding

Levere Holdings Corp.

Quarterly Report on Form

10-Q

Table of Contents


		Page No.
PART I. FINANCIAL INFORMATION			5
Item 1.	Condensed Financial Statements		5
	Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021		5
	Condensed Statements of Operations for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 15, 2021 (inception) through September 30, 2021 (Unaudited)		6
	Condensed Statements of Changes in Shareholders’ Deficit for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 15, 2021 (inception) through September 30, 2021 (Unaudited)		7
	Condensed Statements of Cash Flows for the nine months ended September 30, 2022 and the period from January 15, 2021 (inception) through September 30, 2021 (Unaudited)		8
	Notes to Unaudited Condensed Financial Statements		9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		28
Item 4.	Controls and Procedures		28
PART II. OTHER INFORMATION			29
Item 1.	Legal Proceedings		29
Item1A.	Risk Factors		29
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities		29
Item 3.	Defaults Upon Senior Securities		30
Item 4.	Mine Safety Disclosures		30
Item 5.	Other Information		30
Item 6.	Exhibits		31
SIGNATURES			32

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q includes, and oral statements made from time to time by representatives of the Company may include, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Quarterly Report on Form 10-Q. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings. Forward-looking statements in this Quarterly Report may include, for example, statements about:

•

our ability to select an appropriate target business or businesses;

•

our ability to complete our initial business combination;

•

our expectations around the performance of the prospective target business or businesses;

•

our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;

•

our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;

•

our potential ability to obtain additional financing to complete our initial business combination;

•

our pool of prospective target businesses;

•

our ability to consummate an initial business combination due to the uncertainty resulting from the recent COVID-19 pandemic;

•

the ability of our officers and directors to generate a number of potential business combination opportunities;

•

our public securities’ potential liquidity and trading;

•

the lack of a market for our securities;

•

the use of proceeds not held in the Trust Account (as defined below) or available to us from interest income on the Trust Account balance;

•

the Trust Account not being subject to claims of third parties;

•

our financial performance; and

•

the other risks and uncertainties discussed in the “Risk Factors” sections of our Annual Report on Form 10-K for the year ended December 31, 2021 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, June 30, 2022, and September 30, 2022

The forward-looking statements contained in this Quarterly Report on Form 10-Q are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

LEVERE HOLDINGS CORP.

CONDENSED BALANCE SHEETS


	September 30, 2022			December 31, 2021
	(Unaudited)
Assets
Cash	$	512,975		$	300,844
Due from related party		—			97,419
Prepaid Expenses		175,218			337,935

Total current assets		688,193			736,198
Other assets		—			69,842
Marketable securities held in Trust Account		272,933,281			271,298,677

Total Assets	$	273,621,474		$	272,104,717

Liabilities and Shareholders’ Deficit
Accrued offering costs and expenses	$	51,677		$	505,636
Convertible Promissory Note – Related Party		960,000			—
Due to related party		2,581			—

Total current liabilities	$	1,014,258			505,636
Deferred legal fees		40,328			—
Deferred underwriting fee		9,494,986			9,494,986
Warrant liabilities		699,666			10,264,624

Total Liabilities	$	11,249,238		$	20,265,246

Commitments and Contingencies
Class A Ordinary shares subject to possible redemption, 27,128,532 shares at redemption value		272,933,281			271,298,677
Shareholders’ Deficit:
Preferred shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding		—			—
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no shares issued and outstanding (excluding 27,128,532 shares subject to possible redemption)		—			—
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,782,133 shares issued and outstanding (1)		678			678
Additional paid-in capital (2)		—			—
Accumulated deficit		(10,561,723	)		(19,459,884	)

Total Shareholders’ Deficit		(10,561,045	)		(19,459,206	)

Total Liabilities and Shareholders’ Deficit	$	273,621,474		$	272,104,717

(1)

On January 19, 2021 an aggregate of 7,187,500 founder shares were issued to Goggo Network Gmbh (the “Sponsor”) for an aggregate purchase price of $25,000. Up to 937,500 Founder Shares were subject to forfeiture by the Sponsor, depending on the extent to which the Underwriters’ over-allotment option was exercised. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units and forfeited the remainder of the option. As a result, none of the Class B ordinary shares are subject to forfeiture any longer.

(2)

On January 31, 2022 the Sponsor executed a settlement agreement in the amount of $255,726 relating to Levere’s IPO legal work. The Sponsor agreed to release Levere from all liability obligations associated with the settlement agreement. As a result, the full amount was recorded to additional paid in capital and was subsequently offset by accretion of trust earnings to Class A Ordinary shares subject to possible redemption which depleted the balance in additional paid in capital.

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

LEVERE HOLDINGS CORP.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)


	Three Months Ended September 30,						Nine Months Ended September 30,			For the Period from January 15, 2021 (Inception) through September 30,
	2022			2021			2022			2021
Formation and operating costs	$	241,590		$	258,630		$	922,523		$	463,752

Loss from operations		(241,590	)		(258,630	)		(922,523	)		(463,752	)
Other income (expense):
Interest earned on marketable securities held in Trust Account		1,226,730			4,169			1,634,604			8,626
Offering costs allocated to warrants		—			—			—			(618,405	)
Change in fair value of warrant liabilities		559,732			3,168,957			9,564,958			4,627,726

Total other income (expense), net		1,786,462			3,173,126			11,199,562			4,017,947

Net income	$	1,544,872		$	2,914,496		$	10,277,039		$	3,554,195

Weighted average shares outstanding of Class A ordinary shares		27,128,532			27,128,532			27,128,532			20,044,980

Basic and diluted net income per share, Class A ordinary shares	$	0.05		$	0.09		$	0.30		$	0.13

Weighted average shares outstanding of Class B ordinary shares		6,782,133			6,676,036			6,782,133			6,448,800

Basic and diluted net income per share, Class B ordinary shares	$	0.05		$	0.09		$	0.30		$	0.13

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

LEVERE HOLDINGS CORP.

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

(UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022


	Class A Ordinary shares				Class B Ordinary shares				Additional Paid-in Capital			Accumulated Deficit			Total Shareholders’ Deficit
	Shares		Amount		Shares		Amount		Additional Paid-in Capital			Accumulated Deficit			Total Shareholders’ Deficit
Balance as of December 31, 2021		—	$	—		6,782,133	$	678	$	—		$	(19,459,884	)	$	(19,459,206	)
Net income		—		—		—		—		—			5,580,804			5,580,804
Expenses paid on behalf of the Company by the Sponsor (1)		—		—		—		—		255,726			—			255,726
Accretion of Class A Ordinary shares subject to possible redemption		—		—		—		—		(22,554	)		—			(22,554	)

Balance as of March 31, 2022		—	$	—		6,782,133	$	678	$	233,172		$	(13,879,080	)	$	(13,645,230	)
Net income		—		—		—		—		—			3,151,363			3,151,363
Accretion of Class A Ordinary shares subject to possible redemption		—		—		—		—		(233,172	)		(152,148	)		(385,320	)

Balance as of June 30, 2022		—	$	—		6,782,133	$	678		—		$	(10,879,865	)	$	(10,879,187	)
Net income		—		—		—		—		—			1,544,872			1,544,872
Accretion of Class A Ordinary shares subject to possible redemption		—		—		—		—		—			(1,226,730	)		(1,226,730	)

Balance as of September 30, 2022		—	$	—		6,782,133	$	678	$	—		$	(10,561,723	)	$	(10,561,045	)

(1)

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2021 AND

THE PERIOD FROM JANUARY 15, 2021 (INCEPTION) THROUGH SEPTEMBER 30, 2021


	Class A Ordinary shares				Class B Ordinary shares						Additional Paid-in Capital			Accumulated Deficit			Total Shareholders’ Deficit
	Shares		Amount		Shares			Amount			Additional Paid-in Capital			Accumulated Deficit			Total Shareholders’ Deficit
Balance as of as of January 15, 2021 (Inception)		—	$	—		—		$	—		$	—		$	—		$	—
Class B ordinary shares issued to Sponsor (1)		—		—		7,187,500			719			24,281			—			25,000
Excess Private Placement proceeds received over initial fair value of Private Placement Warrants		—		—		—			—			1,531,807			—			1,531,807
Forfeiture of Class B ordinary shares by initial shareholders		—		—		(532,132	)		(53	)		53			—			—
Net loss		—		—		—			—			—			(800,759	)		(800,759	)
Accretion of Class A Ordinary shares subject to possible redemption		—		—		—			—			(1,556,141	)		(24,225,609	)		(25,781,750	)

Balance as of March 31, 2021		—	$	—		6,655,368		$	666		$	—		$	(25,026,368	)	$	(25,025,702	)
Net income		—		—		—			—			—			1,440,458			1,440,458
Accretion of Class A Ordinary shares subject to possible redemption		—		—		—			—			—			(4,123	)		(4,123	)

Balance as of June 30, 2021		—	$	—		6,655,368		$	666		$	—		$	(23,590,033	)	$	(23,589,367	)
Net income		—		—		—			—			—			2,914,496			2,914,496
Reissuance of forfeited Class B ordinary shares to initial shareholders		—		—		126,765			12			—			(12	)		—
Accretion of Class A Ordinary shares subject to possible redemption		—		—		—			—			—			(4,169	)		(4,169	)

Balance as of September 30, 2021		—	$	—		6,782,133		$	678		$	—		$	(20,679,718	)	$	(20,679,040	)

(1)

On January 19, 2021 an aggregate of 7,187,500 founder shares were issued to the Sponsor for an aggregate purchase price of $25,000. Up to 937,500 Founder Shares were subject to forfeiture by the Sponsor, depending on the extent to which the Underwriters’ over-allotment option was exercised. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units and forfeited the remainder of the option. As a result, none of the Class B ordinary shares are subject to forfeiture any longer.

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

LEVERE HOLDINGS CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)


	For the Nine Months Ended September 30, 2022			For the Period from January 15, 2021 (Inception) through September 30, 2021
Cash flows from operating activities:
Net income	$	10,277,039		$	3,554,195
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in trust account		(1,634,604	)		(8,626	)
Offering costs allocated to warrants		—			618,405
Change in fair value of warrant liability		(9,564,958	)		(4,627,726	)
Expenses paid on behalf of the Company by the Sponsor		55,726			—
Changes in operating assets and liabilities:
Prepaid expenses		162,717			(357,152	)
Other assets		69,842			(154,038	)
Deferred legal fees		40,328			—
Accrued expenses		(253,959	)		36,824
Due to related party		100,000			2,581

Net cash used in operating activities		(747,869	)		(935,537	)

Cash Flows from Investing Activities:
Investment of cash in Trust Account		—			(271,285,320	)

Net cash used in investing activities		—			(271,285,320	)

Cash Flows from Financing Activities:
Proceeds from issuance of Class B ordinary shares to Sponsor		—			25,000
Proceeds from sale of Units, net of underwriting discount		—			265,859,614
Proceeds from sale of Private Placement Warrants		—			7,425,706
Proceeds from promissory note related party		—			211,135
Payments of promissory note related party		—			(211,135	)
Proceeds from convertible promissory note related party		960,000			—
Payment of offering costs		—			(601,480	)

Net cash provided by financing activities		960,000			272,708,840

Net change in cash		212,131			487,983
Cash, beginning of period		300,844			—

Cash, end of the period	$	512,975		$	487,983

Supplemental disclosure of cash flow information:
Initial classification of ordinary shares subject to possible redemption	$	—		$	271,285,654

Expenses paid on behalf of the Company by the Sponsor	$	200,000		$	—

Change in ordinary shares subject to possible redemption	$	1,634,604		$	8,291

Deferred underwriting commissions payable charged to additional paid in capital	$	—		$	9,494,986

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

LEVERE HOLDINGS CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 1 — Organization and Business Operations

Levere Holdings Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on January 15, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses or entities (the “Business Combination”).

As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022 relates to the Company’s formation and the Initial Public Offering (“IPO”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest.

The Company generates non-operating

income in the form of interest income from the proceeds derived from the IPO.

The Company’s sponsor was Levere Holding GG Ltd. (“Levere GG”), a U.K. private company limited by shares. On March 23, 2021, the Company entered into an agreement with Goggo Network GmbH, a German company limited by shares and Levere GG, pursuant to which Levere GG transferred 6,413,571 Class B ordinary shares it holds in the Company to Goggo Network Gmbh. Upon the transfer of shares, Goggo Network Gmbh became the new sponsor of the Company (the “Sponsor”).

The registration statement for the Company’s IPO was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on March 18, 2021. On March 23, 2021, the Company consummated the IPO of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $250,000,000, which is discussed in Note 4. Each Unit consists of one Class A ordinary share,

and

one-third

of one redeemable warrant to purchase one Class A ordinary share at a price of $11.50 per whole share (each whole warrant, a “Public Warrant”).

Simultaneously with the closing of the IPO, the Company consummated the issuance and sale of 4,666,667 warrants (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $7,000,000, which is discussed in Note 5 (the “IPO Private Placement”).

On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units, generating an aggregate of gross proceeds of $21,285,320, incurred $425,706 in cash underwriting fees. The underwriters forfeited the remainder of the option on May 2, 2021.

Simultaneously with the closing of the partial exercise of the over-allotment option, we completed the sale of an additional 283,804 Private Placement Warrants to our Sponsor, at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds of $425,706, which is discussed in Note 5, referred to herein as the Over-Allotment Private Placement, and together with the IPO Private Placement, the Private Placements. On March 31, 2021, our Sponsor surrendered 532,132 Class B ordinary shares for cancellation in connection with the partial exercise of the over-allotment option. The securities in the offering were registered under the Securities Act on a registration statement on Form

S-1

(No.333-253105).

The Securities and Exchange Commission declared the registration statement effective on March 18, 2021.

We subsequently determined that, due to a clerical error in the calculation of the number of Class B ordinary shares to be surrendered to the Company in connection with the partial exercise of the over-allotment option, our Sponsor inadvertently surrendered 126,765 Class B ordinary shares more than the 405,367 Class B ordinary shares that were required to have been forfeited by it in connection with the partial exercise of the over-allotment option, referenced herein as the Clerical Error. Accordingly, on September 16, 2021, we issued 126,765 Class B ordinary shares to our Sponsor, for no consideration, to correct the Clerical Error, such that the total number of Class B ordinary shares forfeited by our Sponsor, after giving effect to the correction of the Clerical Error, was 405,367 Class B ordinary shares.

Table of Contents

Transaction costs of the IPO and the over-allotment option amounted to $15,622,172 consisting of $5,425,706 of underwriting discount, $9,494,986 of deferred underwriting discount, and $701,480 of other offering costs of which $618,405 were allocated to expense associated with the warrant liability.

Following the closing of the IPO on March 23, 2021, and closing of the over-allotment option on March 31, 2021, $271,285,320 ($10.00 per Unit) from the net offering proceeds of the sale of the Units in the IPO and over-allotment, and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7under

the Investment Company Act of 1940, as amended, which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income taxes, if any, the Company’s amended and restated memorandum and articles of association, as discussed below and subject to the requirements of law and regulation, provide that the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account (1) to the Company, until the completion of the initial Business Combination, or (2) to the Public Shareholders (as defined below), until the earliest of (a) the completion of the initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elect to redeem, subject certain limitations described herein, (b) the redemption of any Public Shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association and (c) the redemption of the Company’s Public Shares if the Company has not consummated its Business Combination within 24 months from the closing of IPO (the “Combination Period”), subject to applicable law. Public Shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination within the Combination Period, with respect to such Class A ordinary shares so redeemed. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Public Shareholders.

The Company will provide shareholders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the IPO, with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s income taxes, if any, divided by the number of the then-outstanding Public Shares. The amount in the Trust Account is initially $10.00 per Public Share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the Underwriters.

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their Founder Shares (as defined below), (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to provide

Table of Contents

holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete its initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares, (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete an initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame), and (iv) vote their Founder Shares and Public Shares in favor of the Company’s initial Business Combination.

Liquidity, Capital Resources and Going Concern

As of September 30, 2022, the Company had approximately $0.5 million in its operating bank account and a working capital deficit of approximately $0.3 million or working capital of approximately $0.6 million excluding the convertible promissory note payable.

The Company’s liquidity needs up to March 23, 2021 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 6) for the Founder Shares and the loan under an unsecured promissory note from the Sponsor of up to $300,000 (see Note 6). Subsequent to the consummation of the IPO, the Company’s liquidity needs have been satisfied through the net proceeds from the consummation of the Private Placements not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the officers and directors may, but are not obligated to, provide the Company with working capital loans. As of September 30, 2022, there were $960,000 outstanding under any working capital loan.

Management has determined that they will not have enough cash to meet its obligations as they become due. Management expects to incur significant costs in pursuit of its acquisition plans. The Company believes it will need to raise additional funds in order to meet the expenditures required for operating its business and to consummate a business combination. Moreover, the Company may need to obtain additional financing or draw on the Working Capital Loans (as defined below) either to complete the Business Combination or because it becomes obligated to redeem a significant number of the Public Shares upon consummation of the Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, the Company would only complete such financing simultaneously with the completion of the Business Combination. If the Company is unable to complete the Business Combination because it does not have sufficient funds available, the Company will be forced to cease operations and liquidate the Trust Account. In addition, following the Business Combination, if cash on hand is insufficient, the Company may need to obtain additional financing in order to meet its obligations.

In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”)

2014-15,

“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until March 23, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date and an extension has not been requested by the Sponsor and approved by the Company’s shareholders, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these unaudited condensed financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be unable to continue as a going concern. The Company intends to complete the Business Combination before the mandatory liquidation date. The Company is within 12 months of its mandatory liquidation date as of the time of filing of this Quarterly Report on Form

10-Q.

Table of Contents

Risks and Uncertainties

Results of operations and the Company’s ability to complete the Proposed Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the

COVID-19

pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial business combination.

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

Note 2 – Revision of Previously Issued Financial Statements

The Company notes that the allocation of net income for the calculation of basic and diluted net income per ordinary share for Class A ordinary shares and Class B ordinary shares for the three and nine months ended September 30, 2021 were not reportedly correctly in the notes to the financial statements of the September 30, 2021 Form

10-Q

filed on November 19, 2021. The Company has included this revision note to revise the reported income allocation for the Class A ordinary and Class B ordinary shares within Note 3 – Significant Accounting Policies in the notes to the financial statements for the three and nine months ended September 30, 2021.


	As Previously Reported		Adjustment			As Revised
Basic and diluted net income per ordinary share:
Allocation of Net Income for the three months ended September 30, 2021
Class A	$	2,340,345	$	(1,430	)	$	2,338,915
Class B	$	574,151	$	1,430		$	575,581
Allocation of Net Income for the nine months ended September 30, 2021
Class A	$	2,689,821	$	(746	)	$	2,689,075
Class B	$	864,374	$	746		$	865,120

Note 3 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2022 is not necessarily indicative of the results that may be expected through December 31, 2022 or for any future periods.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form

10-K

filed by the Company with the SEC on April 20, 2022.

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933 (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply

to non-emerging growth

companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.

Table of Contents

Marketable Securities Held in Trust Account

At September 30, 2022 and December 31, 2021, all of the assets held in the Trust Account were held in money market funds which invest U.S. Treasury securities.

Convertible Debt

The Company accounts for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free-standing derivative financial instruments.

The Company reviews the terms of convertible debt issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as

non-operating

income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to interest expense.

Derivative Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and

ASC 815-15.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity,

is re-assessed at

the end of each reporting period.

The Company evaluated the Warrants, which are discussed in Note 4, Note 5 and Note 9, in accordance with

ASC 815-40 and

concluded that a provision in the Warrant Agreement dated March 23, 2021, by and between the Company and Continental Stock Transfer & Trust Company, or the Warrant Agreement, related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in

ASC 815-40, the

Warrants are recorded as derivative liabilities on the Balance Sheets and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the Statement of Operations in the period of change. The fair value of warrants issued by the Company in connection with the IPO and Private Placement has been estimated using Monte-Carlo simulations at the initial measurement date, and at subsequent measurement dates for the Private Placement Warrants. The fair value of the Public Warrants has been determined as of September 30, 2022 and December 31, 2021, by reference to the quoted market price (see Note 9).

Offering Costs Associated with the Initial Public Offering

The Company complies with the requirements of

ASC 340-10-S99-1, “Other Assets and

Deferred Costs.” Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the IPO that were directly related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis, compared to total proceeds received. Offering costs associated with Warrant liabilities are expensed as incurred and

presented as non-operating expenses in the

statement of operations. Offering costs associated with the Class A ordinary shares were charged to shareholders’ deficit upon the completion of the IPO. Transaction costs of the IPO, including the partial exercise of the over-allotment, amounted to $15,622,172, of which $618,405 were allocated to expense associated with the warrant liability.

Table of Contents

Ordinary Shares Subject to Possible Redemption

All of the Class A ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the initial Business Combination and in connection with certain amendments to the Company’s charter. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified

in-ASC 480-10-S99, redemption

provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, at September 30, 2022 and December 31, 2021, all Class A ordinary shares subject to possible redemption is presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets, respectively. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary share to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary share are affected by charges against additional paid in capital and accumulated deficit.

As of September 30, 2022 and December 31, 2021, the ordinary shares subject to redemption reflected on the balance sheets are reconciled in the following table:


Gross proceeds from public issuance	$	271,285,320
Less:
Proceeds allocated to public warrants		(10,677,650	)
Class A ordinary shares issuance cost		(15,003,767	)
Add:
Accretion of carrying value to redemption value		25,694,774

Class A ordinary shares subject to redemption at December 31, 2021	$	271,298,677
Add:
Accretion of carrying value to redemption value		1,634,604

Class A ordinary shares subject to redemption at September 30, 2022	$	272,933,281

Income Taxes

ASC 740 “Accounting for Income Tax” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2022 and December 31, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.

Net Income Per Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period. The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The Company has not considered the effect of warrants sold in the IPO and the private placement to purchase 13,993,314 ordinary shares in the calculation of diluted income per share, because their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the period presented.

Table of Contents

The Company’s statement of operations applies

the two-class method

in calculating net income per share. Basic and diluted net income per ordinary share for Class A ordinary shares and Class B ordinary shares is calculated by dividing net income attributable to the Company by the weighted average number of Class A ordinary shares and Class B ordinary shares outstanding, allocated proportionally to

each

class of shares.

Reconciliation of Net Income per Share

The Company’s net income is adjusted for the portion of net income that is allocable to each class of ordinary shares. The allocable net income is calculated by multiplying net income by the ratio of weighted average number of shares outstanding attributable to Class A and Class B ordinary shares to the total weighted average number of shares outstanding for the period. Accordingly, basic and diluted income per ordinary share is calculated as follows:


	Three Months Ended September 30, 2022				Three Months Ended September 30, 2021				Nine Months Ended September 30, 2022				For the Period from January 25, 2021 (Inception) Through September 30, 2021
	Class A		Class B		Class A		Class B		Class A		Class B		Class A		Class B
Basic and diluted net income per ordinary share
Numerator:
Allocation of net income	$	1,235,898	$	308,974	$	2,338,915	$	575,581	$	8,221,631	$	2,055,408	$	2,689,075	$	865,120
Denominator:
Basic and diluted weighted average shares outstanding		27,128,532		6,782,133		27,128,532		6,676,036		27,128,532		6,782,133		20,044,980		6,448,800

Basic and diluted net income per ordinary share	$	0.05	$	0.05	$	0.09	$	0.09	$	0.30	$	0.30	$	0.13	$	0.13

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

The fair value of the Company’s cash, prepaid expenses, other assets, accrued offering costs and expenses, and due to related party, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximate the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.

Recent Accounting Pronouncements

In August 2020, the FASB issued

ASU 2020-06,

Debt-Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic

815-40):

Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

(“ASU 2020-06”), which

simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU

2020-06

on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Table of Contents

Note 4 — Initial Public Offering

Public Units

On March 23, 2021, the Company sold 25,000,000 Units, at a purchase price of $10.00 per Unit, generating gross proceeds of $250,000,000. The Company granted the underwriters in the IPO (the “Underwriters”) a

45-day

option to purchase up to 3,750,000 additional Units to cover over-allotments, if any. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units, generating an aggregate of gross proceeds of $21,285,320. Each Unit consists of one Class A ordinary share, and

one-third

of one redeemable warrant to purchase one Class A ordinary share.

Public Warrants

Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The Public Warrants will become exercisable at $11.50 per share 30 days after the completion of the initial Business Combination. Only a whole Warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the Units and only whole Warrants will trade. The Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company has agreed that as soon as practicable, but in no event later than 30 calendar days after the closing of the initial Business Combination, it will use commercially reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of its initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the Warrants expire or are redeemed, as specified in the Warrant Agreement; provided that if our Class A ordinary shares are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class A ordinary shares issuable upon exercise of the Warrants is not effective by the 60th day after the closing of the initial Business Combination, Warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

In no event will the Company be required to net cash settle any Warrant. In the event that a registration statement is not effective for the exercised Warrants, the purchaser of a unit containing such Warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit.

Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any

20-trading

days within a

30-trading

day period ending three trading days before the Company sends the notice of redemption to the warrant holders.

Table of Contents

Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

•

in whole and not in part;

•

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the “fair market value” of the Company’s Class A ordinary shares, as defined below;

•

if, and only if, the closing price of the Company’s Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the

30-trading

day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and

•

if the closing price of the Class A ordinary shares for any

20-trading

days within a

30-trading

day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.

The “fair market value” of the Class A ordinary shares for the above purpose shall mean the volume weighted average price of the Company’s Class A ordinary shares during the

10-trading

days immediately following the date on which the notice of redemption is sent to the holders of warrants.

In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. As of September 30, 2022 and December 31, 2021, there were 9,042,843 Public Warrants outstanding.

Note 5 — Private Placement Warrants

Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 4,666,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $7,000,000, in a private placement. Simultaneously with the closing of the exercise of the overallotment option, the Company completed the sale of an additional 283,804 Private Placement Warrants to the Sponsor, at a purchase price of $1.50 per Private Warrant, generating additional gross proceeds of $425,706. A portion of the proceeds from the sales of Private Placement Warrants were added to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of an initial Business Combination.

Table of Contents

The

Private Placement Warrants will be non-redeemable by the Company (except

as described in Note 7) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the IPO. As of September 30, 2022 and December 31, 2021 there were 4,950,471 Private Placement Warrants outstanding.

Note 6 — Related Party Transactions

Founder Shares

On January 19, 2021, the Sponsor purchased 7,187,500 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”) for $25,000, or approximately $0.003 per share, paid to cover certain offering costs. On March 15, 2021, the Company entered into an agreement with Goggo Network GmbH, a German company limited by shares and Levere GG, pursuant to which the Levere GG transferred 6,413,571 Class B ordinary shares it holds in the Company to Goggo Network Gmbh. Upon the transfer of shares, Goggo Network Gmbh became the new sponsor of the Company. Up to 937,500 Founder Shares were subject to forfeiture by the Sponsor, depending on the extent to which the Underwriters’ over-allotment option was exercised. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units and forfeited the remainder of the option.

On March 31, 2021, the Sponsor surrendered to the Company for cancellation, 532,132 Class B ordinary shares. Upon further evaluation, management determined that, due to a clerical error in the calculation of the number of Class B ordinary shares to be surrendered to the Company in connection with the partial exercise of the over-allotment option, the Sponsor inadvertently surrendered 126,765 Class B ordinary shares more than the 405,367 Class B ordinary shares that were required to have been forfeited by it in connection with the partial exercise of the over-allotment option (the “Clerical Error”). Accordingly, on September 16, 2021, the Company issued 126,765 Class B ordinary shares to the Sponsor, for no consideration, to correct the Clerical Error, such that the total number of Class B ordinary shares forfeited by the Sponsor, after giving effect to the correction of the Clerical Error, was 405,367 Class B ordinary shares.

The Sponsor, directors and executive officers have agreed not to transfer, assign or sell any of their Founder Shares until the earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property (the

“Lock-up”).Any

permitted transferees would be subject to the same restrictions and other agreements of the Sponsor, directors and executive officers with respect to any Founder Shares.

Due from (to) Related Party

Commencing on March 23, 2021, the Company agreed to reimburse the Sponsor or an affiliate of the Sponsor for office space, secretarial administrative and other support services provided to members of the management team, in the amount of up to $10,000 per month. Upon completion of the initial Business Combination or the Company’s liquidation, it will cease paying these monthly fees. A total of $2,581 has been accrued as of September 30, 2022 and December 31, 2021.

In addition, the Sponsor owed the Company $100,000 as of December 31, 2021 for legal costs of the Sponsor that it paid. The Sponsor subsequently repaid this amount in February 2022.

Legal Settlement Agreement

Promissory Note — Related Party

On January 19, 2021, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”). This loan was

non-interest

bearing and payable on the earlier of: (i) June 30, 2021 or (ii) the date of the consummation of the IPO. As of March 23, 2021, the Company had borrowed $211,135 under the Note. On March 26, 2021, the Company paid the balance on the note in full.

Table of Contents

Working Capital Loans

In addition, in order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may, at the option of the lender, be converted into Private Placement Warrants at a price of $1.50 per warrant. Such warrants would be identical to the Private Placement Warrants. Except as set forth above, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of the initial Business Combination, the Company does not expect to seek loans from parties other than the Sponsor, its affiliates or any members of the management team as the Company does not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in the Company’s Trust Account.

On May 13, 2022, the Company entered into a Working Capital Loan with the Sponsor pursuant to which the Sponsor agreed to loan the Company up to an aggregate principal amount of $960,000 (the “Convertible Promissory Note”). The Convertible Promissory Note is

non-interest

bearing and payable on the earlier of the date on which the Company consummates a Business Combination or the date that the winding up of the Company is effective. If the Company does not consummate a Business Combination, the Company may use a portion of any funds held outside the Trust Account to repay all or a portion of the Promissory Note; however, no proceeds from the Trust Account may be used for such repayment. If the Company does not have enough funds held outside the Trust Account to repay the Promissory Note in full, the remaining unpaid balance will be forgiven by the Sponsor. Up to $960,000 of the Convertible Promissory Note may be converted into warrants at a price of $1.50 per warrant at the option of the Sponsor. The warrants would be identical to the Private Placement Warrants. As of September 30, 2022, the outstanding principal balance under the Working Capital Loans amounted to an aggregate of $960,000. As of December 31, 2021, the Company had no borrowings under the Working Capital Loans.

The Company assessed the provisions of the Convertible Promissory Note under ASC

470-20.

The derivative component of the obligation is initially valued and classified as a derivative liability. The conversion option was valued using Monte Carlo simulation model, which is considered to be a Level 3 fair value measurement and based on the following assumptions:


	September 30, 2022			May 13, 2022 Borrowing (Initial Measurement)
Underlying warrant value	$	0.05		$	0.122
Exercise price	$	1.50		$	1.50
Holding period		0.50			0.76
Risk-free rate %		4.02	%		1.76	%
Volatility %		0.70	%		1.40	%
Dividend yield %		0.0	%		0.0	%

At September 30, 2022 and May 13, 2022, the Company determined that the conversion option liability had a fair value of $0. In accordance with this determination, no conversion option liability or debt discount was recorded as of September 30, 2022.

Table of Contents

Note 7 — Commitments and Contingencies

Registration Rights

The holders of the Founder Shares, Private Placement Warrants, and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement entered into in connection with the IPO (the “Registration Rights Agreement”). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of an initial Business Combination. However, the Registration Rights Agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable

Lock-up

period, which occurs (i) in the case of the Founder Shares as described in the following paragraph, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Our Sponsor and our directors and executive officers have agreed not to transfer, assign or sell their founder shares until the earliest of (A) one year after the completion of our initial business combination; and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and thelike)

for any 20-trading days within any 30-trading day period

commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares.

Underwriting Agreement

The Company granted the Underwriters a

45-day

option from March 23, 2021 to purchase up to an additional 3,750,000 units to cover over-allotments, if any. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units and forfeited the remainder of the option.

On March 23, 2021, the Company paid an underwriting discount of $5,000,000, and on March 31, 2021, the Company paid an additional underwriting discount of $425,706 for Units sold pursuant to the over-allotment option. Additionally, the Underwriters are entitled to deferred underwriting fee of 3.5% of the gross proceeds of the IPO and over-allotment, or $9,494,986 in the aggregate. The deferred fee will become payable to the Underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Note 8 — Shareholders’ Deficit and Shares Subject to Possible Redemption

Preference Shares

— The Company is authorized to issue 5,000,000 preference shares at par value of $0.0001 each and provide that preference shares may be issued from time to time in one or more series. The Company’s board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. At September 30, 2022 and December 31, 2021, there were no preference shares issued or outstanding.

Class

A Ordinary shares

— The Company is authorized to issue a total of 500,000,000 Class A ordinary shares at par value of $0.0001 each. At September 30, 2022 and December 31, 2021, there were no shares issued and outstanding, excluding 27,128,532 shares which are subject to possible redemption and classified as temporary equity.

Class

B Ordinary shares

— The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each Class B ordinary share. At September 30, 2022 and December 31, 2021, there were 6,782,133 Class B ordinary shares issued and outstanding.

Holders of the Class A ordinary shares and holders of the Class B ordinary shares vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law. Unless specified in the Company’s amended and restated certificate of incorporation or as required applicable provisions of the Companies Act (2021 Revision) of the Cayman Islands or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by its shareholders.

Table of Contents

Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least

two-thirds

of the Company’s ordinary shares that are voted, and pursuant to the Company’s amended and restated memorandum and articles of association; such actions include amending its amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company.

The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) prior to, at the time of, or after its initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an

as-converted-

basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the IPO, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than

one-to-one.

Note 9 — Fair Value Measurements

The Company follows the guidance in ASC 820, “Fair Value Measurement”, for its financial assets and

liabilities that are re-measured and reported at

fair value at each reporting period, and nonfinancial assets and liabilities that arere-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:


Level 1	—	Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

Level 2	—	Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

Level 3	—	Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

Table of Contents

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:


	September 30, 2022		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
U.S. Money Market held in Trust Account	$	272,933,281	$	272,933,281	$	—	$	—

	$	272,933,281	$	272,933,281	$	—	$	—

Liabilities:
Public Warrants Liability	$	452,142	$	452,142	$	—	$	—
Private Placement Warrants Liability		247,524		—		—		247,524

	$	699,666	$	452,142	$	—	$	247,524

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:


	December 31, 2021		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
U.S. Money Market held in Trust Account	$	271,298,677	$	271,298,677	$	—	$	—

	$	271,298,677	$	271,298,677	$	—	$	—

Liabilities:
Public Warrants Liability	$	6,601,275	$	6,601,275	$	—	$	—
Private Placement Warrants Liability		3,663,349		—		—		3,663,349

	$	10,264,624	$	6,601,275	$	—	$	3,663,349

The Warrants are accounted for as liabilities in

accordance with ASC 815-40 and are

presented within warrant liabilities on the condensed balance sheets. The Warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of Warrant liabilities in the condensed statements of operations.

The Company established the initial fair value of the Public Warrants and Private Placement Warrants on March 23, 2021, the date of the Company’s IPO, using a Monte Carlo simulation model. On December 31, 2021, the Company established the fair value of the Private Warrants using a Monto Carlo simulation model, and the fair value of the Public Warrants by reference to the quoted market price. The Public and Private Warrants were classified as Level 3 at the initial measurement date and the Private Warrants were classified as Level 3 at December 31, 2021 due to the use of unobservable inputs. As of December 31, 2021, the Public Warrants were transferred to Level 1 due to the use of the quoted market price.

Table of Contents

The following tables present the changes in Level 3 liabilities at September 30, 2022 and December 31, 2021:


Fair Value at December 31, 2021	$	3,663,349
Change in fair value of private warrants		(2,128,703	)

Fair Value at March 31, 2022	$	1,534,646
Change in fair value of private warrants		(1,089,104	)

Fair Value at June 30, 2022	$	445,542
Change in fair value of private warrants		(198,018	)

Fair Value at September 30, 2022	$	247,524

Fair Value at January 15, 2021 (inception)	$	—
Initial fair value of public and private warrants		15,386,666
Initial fair value of public and private warrants issued with over-allotment		1,184,882
Change in fair value of public and private warrants		(3,141,929	)
Transfer of public warrants to Level 1		(9,766,270	)

Fair Value at December 31, 2021	$	3,663,349

The key inputs into the Monte Carlo simulation as of September 30, 2022, December 31, 2021 and March 23, 2021 were as follows:


Inputs	September 30, 2022			December 31, 2021
Risk-free interest rate		4.20	%		1.35	%
Expected term remaining (years)		3.58			6.0
Expected volatility		0.7	%		14	%
Share price	$	9.90		$	9.74

Note 10 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheets date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “our,” “us” or “we” refer to Levere Holdings Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Overview

We are a blank check company incorporated as a Cayman Islands exempted company on January 15, 2021, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, or a Business Combination. Our sponsor is Goggo Network Gmbh, a German company limited by shares, or our Sponsor.

The registration statement for our initial public offering, or IPO, was declared effective on March 18, 2021. On March 23, 2021, we consummated the IPO of 25,000,000 Units (as defined below), at $10.00 per Unit, generating gross proceeds of $250.0 million. The Company granted the Underwriters in the IPO, or the Underwriters, a 45-day option to purchase up to 3,750,000 additional Units to cover over-allotments, if any. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units, generating an aggregate of gross proceeds of approximately $21.3 million. Each Unit consists of one Class A ordinary share, and one-third of one redeemable warrant to purchase one Class A ordinary share, or a Public Warrant, at a price of $11.50 per whole share, or the “Units” and, with respect to the Class A ordinary shares included in the Units sold, or the Public Shares. We incurred transaction costs for the IPO and over-allotment of approximately $15.6 million, inclusive of approximately $9.5 million in deferred underwriting commissions.

Simultaneously with the closing of the IPO, we consummated the private placement of 4,666,667 warrants at a price of $1.50 per warrant, or the Private Placement Warrants, and together with the Public Warrants, the Warrants, to the Sponsor, generating gross proceeds of $7.0 million, or the IPO Private Placement. Simultaneously with the closing of the exercise of the overallotment option, we completed the sale of an aggregate of an additional 283,804 Private Placement Warrants to the Sponsor, at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds of approximately $0.4 million, or the Over-Allotment Private Placement and together with the IPO Private Placement, the Private Placements.

Upon the closing of the IPO and exercise of the over-allotment option, and the simultaneous Private Placements, approximately $271.3 million ($10.00 per Unit) of the net proceeds were placed in a trust account, or Trust Account, located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities,” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

If we have not completed a Business Combination within 24 months from the closing of the IPO, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

Results of Operations

For the three months ended September 30, 2022, we had a net income of approximately $1.5 million, which is primarily comprised of a gain from the change in fair value of warrant liabilities of approximately $0.6 million and interest earned on marketable securities of $1.2 million, partially offset by a loss from operations of approximately $0.2 million.

For the nine months ended September 30, 2022, we had a net income of approximately $10.3 million, which is primarily comprised of a gain from the change in fair value of warrant liabilities of approximately $9.6 million and interest earned on marketable securities of $1.6 million, partially offset by a loss from operations of approximately $0.9 million.

For the three months ended September 30, 2021, we had a net income of approximately $2.9 million, which included a loss from operations of $0.3 million and a gain from the change in fair value of warrant liabilities of $3.2 million.

For the period from January 15, 2021 to September 30, 2021, we had a net income of approximately $3.5 million, which included a loss from operations of $0.5 million, offering cost expense allocated to warrants of $0.6 million, and a gain from the change in fair value of warrant liabilities of $4.6 million.

Our business activities from inception to September 30, 2022 consisted primarily of our formation and completing our IPO and, since the completion of our IPO, our activity has been limited to identifying and evaluating prospective acquisition targets for a Business Combination.

Liquidity, Capital Resources and Going Concern

As of September 30, 2022, we had approximately $0.5 million in our operating bank account, and a working capital deficit of approximately $0.3 million, or working capital of approximately $0.6 million excluding the convertible promissory note payable.

Our liquidity needs up to March 23, 2021 had been satisfied through (i) a capital contribution from our Sponsor of $25,000 for the 7,187,500 Class B ordinary shares, par value $0.0001 per share, or the Founder Shares, and (ii) proceeds from the loan under an unsecured promissory note from our Sponsor of up to $300,000. Subsequent to the consummation of our IPO, our liquidity needs have been satisfied through the net proceeds from the Private Placements not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors may, but are not obligated to, provide us working capital loans. On May 13, 2022, we entered into a convertible promissory note with the Sponsor pursuant to which the Sponsor agreed to loan us up to an aggregate principal amount of $960,000. Concurrently with entering into the debt agreement, we borrowed $960,000 against the convertible promissory note. The proceeds from the note will be used to for working capital purposes and to finance transaction costs in connection with a Business Combination. See Note 6 to our unaudited financial statements for further discussion of the convertible promissory note. As of September 30, 2022, the outstanding principal balance under the convertible promissory note amounted to an aggregate of $960,000.

In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until March 23, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date and an extension has not been requested by the Sponsor and approved by the Company’s shareholders, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that if the Company is unable to raise additional funds to alleviate liquidity needs then the Company will cease all operations except for the purpose of liquidating. The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be unable to continue as a going concern. The Company intends to complete the Business Combination before the mandatory liquidation date of March 23, 2023. The Company is within 12 months of its mandatory liquidation as of the time of filing this Quarterly Report on Form 10-Q

Contractual Obligations

As of September 30, 2022, we did not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or other long-term liabilities, other than an agreement to pay the sponsor a monthly fee of $10,000 for office space, utilities, secretarial support and administrative services. We began incurring these fees on March 23, 2021 and will continue to incur these fees monthly until the earlier of the completion of an initial business combination and our liquidation.

The underwriters of the IPO are entitled to a deferred underwriting commission of 3.5% of the gross proceeds of the IPO and over-allotment, or $9,494,986 in the aggregate. The deferred fee will become payable to the Underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Estimates

This management’s discussion and analysis of our financial condition and results of operations is based on our unaudited condensed financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our unaudited condensed financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Warrants Liability

We evaluated the Warrants in accordance with ASC 815-40 and concluded that a provision in the Warrant Agreement, dated March 23, 2021, by and between us and Continental Stock Transfer & Trust Company related to certain tender or exchange offers as well as provisions that provided for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant, precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815-40 and are not eligible for an exception from derivative accounting, the Warrants are recorded as derivative liabilities on our Balance Sheets and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in our Statement of Operations in the period of change.

Convertible Promissory Note

We account for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free-standing derivative financial instruments.

We review the terms of convertible debt issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to interest expense.

We assessed the provisions of the Convertible Promissory Note under ASC 470-20. The derivative component of the obligation is initially valued and classified as a derivative liability. The conversion option was valued using a Monte Carlo simulation model, which is considered to be a Level 3 fair value measurement. The conversion option liability is not recorded as of September 30, 2022 as it was determined to have no fair value.

Offering Costs Associated with the Initial Public Offering

We comply with the requirements of the ASC 340-10-S99-1, “Other Assets and Deferred Costs.” Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the IPO that were directly related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis, compared to total proceeds received. Offering costs associated with Warrant liabilities are expensed as incurred, presented as non-operating expenses in our Statement of Operations. Offering costs associated with the Class A ordinary shares were charged to shareholders’ deficit upon the completion of the IPO. Transaction costs of the IPO, including the partial exercise of the over-allotment, amounted to $15,622,172, of which $618,405 were allocated to expense associated with the Warrant liability.

Ordinary Shares Subject to Possible Redemption

All of the Class A ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with our liquidation, if there is a shareholder vote or tender offer in connection with the initial Business Combination and in connection with certain amendments to our charter. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within our control require ordinary shares subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, at September 30, 2022 and December 31, 2021, all Class A ordinary shares subject to possible redemption is presented as temporary equity, outside of the shareholders’ deficit section of our condensed balance sheets.

We recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary share to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary share are affected by charges against additional paid in capital and accumulated deficit.

Net Income Per Share

We comply with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period. We have two classes of shares, Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. We have not considered the effect of warrants sold in the IPO and the Private Placements to purchase 13,993,314 ordinary shares in the calculation of diluted net income per share, since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the period presented.

Our statement of operations applies the two-class method in calculating net income per share. Basic and diluted net income per ordinary share for Class A ordinary shares and Class B ordinary shares is calculated by dividing net income attributable to us by the weighted average number of Class A ordinary shares and Class B ordinary shares outstanding, allocated proportionally to each class of shares.

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU2 020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Our management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

Emerging Growth Company and Smaller Reporting Company Status

As an emerging growth company, or EGC, under the Jumpstart Our Business Startups Act of 2012, or JOBS Act, we may delay the adoption of certain accounting standards until such time as those standards apply to private companies. Other exemptions and reduced reporting requirements under the JOBS Act for EGCs include presentation of only two years of audited financial statements in a registration statement for an IPO, an exemption from the requirement to provide an auditor’s report on internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002, an exemption from any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation, and less extensive disclosure about our executive compensation arrangements.

In addition, the JOBS Act provides that an EGC can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an EGC to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have elected not to “opt out” of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we can adopt the new or revised standard at the time private companies adopt the new or revised standard and may do so until such time that we either (1) irrevocably elect to “opt out” of such extended transition period or (2) no longer qualify as an emerging growth company. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

We are also a “smaller reporting company,” as defined in the Exchange Act of 1934, or the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company, in which case we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer (our principal executive and principal financial officer), we conducted an evaluation of the effectiveness of our disclosure controls and procedures, as such term is defined in Rules 13a-15I and 15d-15(e) under the Exchange Act, as of the end of the quarter ended September 30, 2022. Based on this evaluation our principal executive and principal financial (“Certifying Officer”) has concluded that during the period covered by this report, our disclosure controls and procedures were not effective. Our internal control over financial reporting did not result in the proper accounting classification of complex financial instruments and the accounting for accruals for certain expenses. As a result, we performed additional analyses as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material respects, our financial position, result of operations and cash flows of the periods presented.

Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Certifying Officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

Other than the matter disclosed above, and the additional procedures described below, there was no change in our internal control over financial reporting that occurred during the quarter ended September 30, 2022 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

As disclosed above, management has identified material weaknesses in internal controls related to the proper accounting classification of complex financial instruments and the accounting for accruals for certain expenses. In light of the material weaknesses identified, we plan to continue to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

PARTII-OTHERINFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors.

Investing in our securities involves a high degree of risk. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on April 20, 2022 (the “2021 Form 10-K”) and Part II, Item 1A Risk Factors in our Quarterly Reports on Form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 26, 2022, and for the quarter ended June 30, 2022, filed with the SEC on August 16, 2022, which could materially affect our business, financial condition, or future results.

The Excise Tax included in the Inflation Reduction Act of 2022 may decrease the value of our securities, hinder our ability to consummate an initial business combination, and decrease the amount of funds available for distribution in connection with a redemption or liquidation.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock or shares by publicly traded domestic corporations and certain domestic subsidiaries of publicly traded foreign corporations (the “Excise Tax”). The Excise Tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock or share issuances against the fair market value of stock or share repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. Treasury has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with an initial business combination — particularly one that involves our combination with a U.S. entity and/or our re-domestication as a U.S. corporation —may be subject to the Excise Tax.1 Whether and to what extent we would be subject to the Excise Tax would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the initial business combination, (ii) the structure of the initial business combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with the initial business combination (or otherwise issued not in connection with the initial business combination but issued within the same taxable year of the initial business combination) and (iv) the content of regulations and other guidance from the U.S. Department of the Treasury. In addition, because the Excise Tax would be payable by us, and not by the redeeming holder, the mechanics of any required payment of the Excise Tax have not been determined. Consequently, the value of your investment in our securities may decrease as a result of the Excise Tax. In addition, the Excise Tax may make a transaction with us less appealing to potential business combination targets, and thus, potentially hinder our ability to enter into and consummate an initial business combination.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities

Use of Proceeds

On March 23, 2021, we consummated our IPO of 25,000,000 Units. Each Unit consists of one Class A ordinary share, and one-third of one redeemable warrant to purchase one Class A ordinary share at a price of $11.50 per whole share. Citigroup Global Markets Inc. and Deutsche Bank Securities Inc. acted as representatives of the Underwriters. The Units were sold at a price of $10.00 per Unit, generating gross proceeds of $250.0 million. We granted the Underwriters a 45-day option to purchase up to an additional 3,750,000 units at the IPO price to cover over-allotments, if any. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units generating gross proceeds of $21.3 million. On March 31, 2021, our Sponsor surrendered 532,132 Class B ordinary shares for cancellation in connection with the partial exercise of the over- allotment option. The securities in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-253105). The Securities and Exchange Commission declared the registration statement effective on March 18, 2021.

Upon further evaluation, management determined that, due to a clerical error in the calculation of the number of Class B ordinary shares to be surrendered to us in connection with the partial exercise of the over-allotment option, the Sponsor inadvertently surrendered 126,765 Class B ordinary shares more than the 405,367 Class B ordinary shares that were required to have been forfeited by it in connection with the partial exercise of the over-allotment option (the “Clerical Error”). Accordingly, on September 16, 2021, we issued 126,765 Class B ordinary shares to the Sponsor, for no consideration, to correct the Clerical Error, such that the total number of Class B ordinary shares forfeited by the Sponsor, after giving effect to the correction of the Clerical Error, was 405,367 Class B ordinary shares.

Substantially concurrently with the closing of the IPO, we completed the private sale of 4,666,667 Private Placement Warrants, at a purchase price of $1.50 per Private Placement Warrant, to our Sponsor, generating gross proceeds of $7.0 million. In connection with the Underwriters’ partial exercise of their over-allotment option, our Sponsor purchased an additional 283,804 Private Placement Warrants, generating gross proceeds of approximately $0.4 million.

In connection with the IPO and the over-allotment, we incurred offering costs of $15,622,172, inclusive of approximately $9.5 million in deferred underwriting commissions. Other incurred offering costs consisted principally of preparation fees related to the IPO. After deducting the underwriting discounts and commissions (excluding the deferred portion, which amount will be payable upon consummation of the initial Business Combination, if consummated) and the IPO expenses, approximately $271.3 million of the net proceeds from our IPO, the over-allotment and certain of the proceeds from the private placement of the Private Placement Warrants (or $10.00 per Unit sold in the IPO) were placed in the Trust Account. See Note 1 to the unaudited condensed financial statements for additional detail.

We have agreed to pay the Underwriters up to an additional $9.5 million on account of certain deferred underwriting fees in connection with the initial Business Combination; provided, however, that the Underwriters will not be paid such additional fees if we do not complete the initial Business Combination.

There has been no material change in the planned use of the proceeds from the IPO and Private Placement as is described in our final prospectus related to the IPO.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

On November 8, 2022, our board of directors appointed Martin Varsavsky, our chief executive officer, to serve as our interim Chief Financial Officer (principal financial officer).

For Mr. Varsavsky’s biographical information and disclosure related to certain transactions between us and Mr. Varsavsky, see the disclosure include under Item 10. Directors, Executive Officers and Corporate Governance on page 61 of the 2021 Form 10-K and Item 13. Certain Relationships and Related Transactions, and Director Independence on pages 66 through 68 of the 2021 Form 10-K, which disclosure is incorporated herein by reference.

Item 6. Exhibits.


Exhibit Number		Description

3.1		Amended and Restated Memorandum and Articles of Association.¹

31.1		Certification of Principal Executive and Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1		Certification of Principal Executive and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

101.INS		Inline XBRL Instance Document

101.SCH		Inline XBRL Taxonomy Extension Schema Document

10l.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (embedded within the Inline XBRL document and incorporated as Exhibit 101).

*	Filed herewith.

¹	Previously filed as an exhibit to our Current Report on Form 8-K filed on March 23, 2021 and incorporated by reference herein.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on this 8th day of November 2022.


LEVERE HOLDINGS CORP.

By:		/s/ Martin Varsavsky
Name:		Martin Varsavsky
Title:		Chief Executive Officer and Chief Financial Officer

Large accelerated filer

Accelerated filer

Non-accelerated
filer

Smaller reporting company

Emerging growth company

Levere Holdings Corp. 10-Q